Beyond one virus: vaccination against hepatitis B after hepatitis C treatment

Lancet Infect Dis. 2018 Mar;18(3):246-247. doi: 10.1016/S1473-3099(18)30076-8.

Authors

Jose D Debes¹, Dupinder Singh²

Affiliations

¹ Department of Medicine, Division of Infectious Disease and International Medicine, University of Minnesota, Minneapolis, MN, USA; Department of Gastroenterology and Hepatology, Hennepin County Medical Center, Minneapolis, MN 55415, USA. Electronic address: debes003@umn.edu.
² Division of Gastroenterology and Hepatology, University of Minnesota, Minneapolis, MN, USA.

PMID: 29485084
DOI: 10.1016/S1473-3099(18)30076-8

No abstract available

Publication types

Letter
Comment

MeSH terms

Adult
Aminoisobutyric Acids
Benzimidazoles
Cyclopropanes
Expeditions*
Genotype
Hepatitis B
Hepatitis C, Chronic*
Humans
Lactams, Macrocyclic
Leucine / analogs & derivatives
Liver Cirrhosis
Proline / analogs & derivatives
Pyrrolidines
Quinoxalines
Sulfonamides
Vaccination

Substances

Aminoisobutyric Acids
Benzimidazoles
Cyclopropanes
Lactams, Macrocyclic
Pyrrolidines
Quinoxalines
Sulfonamides
pibrentasvir
Proline
Leucine
glecaprevir